In a recent article published on Pharmaceutical Executive, we look at the Emergence of Cancer Vaccines: Reframing Value Demonstration, Pricing, and Access

A global pharmaceutical company was planning to launch a next generation vaccine into a competitive market with the aim of replacing the current standard of care, which was a vaccine that they also owned.